Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) is now available.
Daito Pharmaceutical Co., Ltd. reported its consolidated financial results for the fiscal year ending May 31, 2025, showing an 8% increase in net sales to ¥50,643 million. However, the company experienced a significant decline in profits, with operating profit down by 32.7% and ordinary profit by 31%. The company also announced a forecast for the fiscal year ending May 31, 2026, expecting a 3.7% increase in net sales and a 14.5% rise in operating profit, indicating a positive outlook despite recent challenges.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. It focuses on the development and sale of pharmaceutical products, with a market focus on both domestic and international sectors.
Average Trading Volume: 78,388
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen30.87B
See more data about 4577 stock on TipRanks’ Stock Analysis page.